New drug for AIDS-related eye infection. (cytomegalovirus retinitis; cidofovir)(Brief Article) From: FDA Consumer | Date: October 1, 1996 | COPYRIGHT 1996 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

A new drug is available for treating cytomegalovirus (CMV) retinitis, a potentially severe eye infection that can lead to blindness.

While other therapies must be given daily, the new intravenous treatment, Vistide (cidofovir), is administered once a week for the first two weeks and then once every two weeks.

FDA based its June 26 approval on two studies in a total of 148 patients. One study showed that the retinitis progressed more slowly in patients treated...

Related newspaper, magazine, and journal articles from HighBeam Research

Experimental drug allowed for AIDS-related eye infections.(cidofir authorized to treat relapsing cytomegalovirus retinitis)(Brief Article) FDA Consumer ; ... by FDA, doctors may use the investigational drug intravenous Vistide (cidofovir) to treat HIV-infected patients with relapsing cytomegalovirus (CMV) retinitis that has progressed despite treatment. CMV retinitis is an eye infection that can lead to blindness in people ...

See all results.